Ascletis Pharma (1672.HK) Q3 2026 Earnings

31AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.35
-0.27
-0.18
-0.1

Details

Expected EPS
-0.230719368
Actual EPS
-0.35461566861599997
Surprise EPS
-0.12
Surprise Percent
+53.7%

Description

Ascletis Pharma (1672.HK) has reported earnings of -0.35461566861599997 per share for Q3 2026.

0 Comments

Share your thoughts